BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26357655)

  • 1. Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma.
    Lu J; Pan Y; Xia X; Gu Y; Lei Y
    Biomed Res Int; 2015; 2015():417210. PubMed ID: 26357655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Jiang Q; Chen J; Zhang B; Niu J; He Y
    Med Sci Monit; 2017 Jun; 23():3200-3208. PubMed ID: 28665915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
    Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.
    Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH
    Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
    He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
    Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma.
    Tachibana M; Shibakita M; Ohno S; Kinugasa S; Yoshimura H; Ueda S; Fujii T; Rahman MA; Dhar DK; Nagasue N
    Cancer; 2002 Apr; 94(7):1955-60. PubMed ID: 11932897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
    Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
    Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
    Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
    Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
    Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
    Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 13. Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis.
    Wang S; Wang Z; Yang Z; Liu Y; Liu X; Shang B; Jiang WP
    Ann Surg Oncol; 2016 Jan; 23(1):265-72. PubMed ID: 26014154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma.
    Meng YQ; Cao X; Wen ZS; Liu QW; Tan ZH; Duan H; Ma GW; Lin P
    Dis Esophagus; 2014; 27(7):670-7. PubMed ID: 24033446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer.
    de Kort WWB; de Ruiter EJ; Haakma WE; Driehuis E; Devriese LA; van Es RJJ; Willems SM
    Head Neck Pathol; 2023 Sep; 17(3):697-707. PubMed ID: 37486536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
    Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
    Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
    Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma.
    Han L; Song Q; Jia Y; Chen X; Wang C; Chen P; Min R; Cheng Y
    Tumour Biol; 2016 Mar; 37(3):3081-90. PubMed ID: 26423404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
    Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.